4.7 Article

Future gazing in the management of multiply drug-resistant Gram-positive infection

Journal

JOURNAL OF INFECTION
Volume 59, Issue -, Pages S75-S80

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/S0163-4453(09)60010-4

Keywords

Antimicrobial selection; Multidrug resistance; Gram-positive bacteria; Guidelines; Linezolid; MRSA

Funding

  1. Pfizer Inc

Ask authors/readers for more resources

Gram-positive bacteria have evolved to become predominant health care associated pathogens. To meet this challenge, novel approaches to the development, prescribing, and control of antibiotics will be needed. Additional infection control methods must also be explored. This review discusses the challenges posed in particular by methicillin-resistant staphylococci and potential ways forward. (c) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available